Stock Events

Bio-Rad Laboratories 

$276.94
102
+$6.87+2.54% Friday 20:00

Statistics

Day High
277.63
Day Low
270.44
52W High
431.79
52W Low
261.59
Volume
193,966
Avg. Volume
325,820
Mkt Cap
7.97B
P/E Ratio
-24.84
Dividend Yield
-
Dividend
-

Earnings

7MayConfirmed
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
2.15
2.63
3.11
3.59
Expected EPS
2.15
Actual EPS
2.29

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BIO. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Thermo Fisher Scientific
TMO
Mkt Cap211.09B
Thermo Fisher Scientific offers a broad range of products and services in the life sciences sector, directly competing with Bio-Rad's offerings in laboratory equipment and consumables.
Danaher
DHR
Mkt Cap185.06B
Danaher Corporation operates in similar segments as Bio-Rad, including life sciences and diagnostics, making them direct competitors in multiple product lines.
Illumina
ILMN
Mkt Cap16.63B
Illumina specializes in genomics and DNA sequencing technologies, competing with Bio-Rad's products in the genomics field.
Agilent Technologies
A
Mkt Cap37.82B
Agilent Technologies competes with Bio-Rad in the life sciences and diagnostics sectors, particularly in laboratory instruments and supplies.
Bio-Rad Laboratories - Ordinary Shares
BIO.B
Mkt Cap7.84B
Bio-Rad Laboratories Class B shares represent a different class of stock of the same company but are listed separately, directly tied to the company's performance.
Waters
WAT
Mkt Cap17.21B
Waters Corporation provides analytical instruments for the life sciences sector, competing with Bio-Rad's chromatography and mass spectrometry products.
Bruker
BRKR
Mkt Cap9.27B
Bruker Corporation is a competitor in the life science analytical and diagnostic instruments sector, directly competing with several of Bio-Rad's product lines.
Qiagen NV
QGEN
Mkt Cap9.38B
QIAGEN is a provider of sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research, competing with Bio-Rad in the diagnostics and research sectors.
Baxter International
BAX
Mkt Cap17.05B
Baxter International operates in the medical devices and life sciences fields, competing with Bio-Rad in the broader healthcare and scientific research sectors.

Analyst Ratings

386.25$Average Price Target
The highest estimate is $480.
From 4 ratings within the last 6 months. This is not an investment recommendation.
Buy
50%
Hold
50%
Sell
0%

About

Health Technology
Medical Specialties
Manufacturing
Analytical Laboratory Instrument Manufacturing
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Show more...
CEO
Norman Schwartz
Employees
8000
Country
US
ISIN
US0905722072
WKN
000865406

Listings